Please assess the completion status of the following clinical trial:

Trial Title: A Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Allergic Conjunctivitis

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Has a positive history of ocular allergies and a positive skin test reaction to a perennial allergen and a seasonal allergen~* Has a positive bilateral CAC reaction to a perennial allergen within minutes of instillation~Exclusion Criteria:~* History of refractive surgery (including LASIK procedures) within the past 2 years~* History of retinal detachment, diabetic retinopathy, or active retinal disease~* Presence of an active ocular infection or positive history of an ocular herpetic infection at any visit~* History of IOP increase as a result of steroid treatment~* A female who is currently pregnant, planning a pregnancy, or lactating

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- OTX-DP (Type: EXPERIMENTAL): None
- Placebo (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).